Company / Current Assets per Share
Ultragenyx Pharmaceutical Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$10.28
FY2025
5-year range
$9.93 / $12.82
FY2021-FY2025
Trend
+3.6%
vs FY2024
Sector context
#73 of 210
Health Care
What the data says
At $10.28, Ultragenyx Pharmaceutical Inc.'s current assets per share ranks #73 of 210 in the Health Care sector. Current Assets per Share returned to growth in FY2025 after 4 years of decline, reaching $10.28.
Based on SEC 10-K filings.
10.28 in FY2025 with a 5-year CAGR of -14.4%.
Remained stable around $10.28 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -6.9%
- 5-Year CAGR
- -14.4%
- 10-Year CAGR
- -
Sector benchmark
#73 of 210 in Health CareTop 35% of 210This company $10.28 Sector average $170.65
▼
-94.0% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 3.6% year-over-year.
- Ranks #73 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.28 | +3.6% |
| FY2024 | $9.93 | -4.8% |
| FY2023 | $10.43 | -18.2% |
| FY2022 | $12.75 | -0.6% |
| FY2021 | $12.82 | -42.8% |
| FY2020 | $22.40 | +33.8% |
| FY2019 | $16.73 | +41.5% |
| FY2018 | $11.83 | +80.9% |
| FY2017 | $6.54 | -36.7% |
| FY2016 | $10.33 | -15.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026